Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1465 Articles

Jon C. Ogg | Feb 14, 2016 at 9:32 AM EST

6 Biotech and Pharma Stocks Analysts Want You to Buy Now

Here are six biotech and pharma stocks that analysts are telling their firm's clients to buy now for solid upside…

Chris Lange | Feb 10, 2016 at 9:15 AM EST

Short Sellers Increase Bets in Major Pharma

The January 29 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Trey Thoelcke | Feb 10, 2016 at 6:15 AM EST

The 6 Most Shorted NYSE Stocks: Short Sellers Pile on Alcoa, Freeport-McMoRan Again

Among the six most heavily shorted stocks traded on the New York Stock Exchange, short sellers continued to pile on…

Chris Lange | Feb 9, 2016 at 11:35 AM EST

Why Merrill Lynch Sees Big Upside in Pfizer (and Even More With Allergan)

Merrill Lynch has decided to add Pfizer as its new top pick for 2016. The firm reiterated a Buy rating…

Jon C. Ogg | Feb 9, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce, Tesla, Yelp and More

The top analyst upgrades, downgrades and initiations seen on Tuesday include Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce,com,…

Lee Jackson | Feb 8, 2016 at 8:25 AM EST

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

If you ever want to look for value in a sector in the stock market, then when you see Congress…

Chris Lange | Feb 7, 2016 at 10:15 AM EST

How Analysts View Pfizer and Merck After Earnings

After Pfizer and Merck released their most recent earnings reports last week, analysts weighed in on both of these pharmaceutical…

Lee Jackson | Feb 4, 2016 at 10:45 AM EST

Merrill Lynch Has 4 Very Oversold Blue Chip Dividend Stocks to Buy Now

Needless to say, the stock market can be a very cruel mistress. So what are patient long-term investors to do?

Paul Ausick | Feb 2, 2016 at 8:05 AM EST

Investors OK With Pfizer Earnings, Not OK With Guidance

Pfizer reported better-than-expected fourth-quarter and full-year 2015 results before markets opened Tuesday morning.

Chris Lange | Feb 1, 2016 at 1:25 PM EST

What to Expect From Pfizer Earnings

Pfizer is scheduled to report its fourth-quarter financial results before the markets open on Tuesday.

Chris Lange | Jan 31, 2016 at 10:10 AM EST

Top 3 Dow Earnings for the Coming Week

24/7 Wall St. has put together a preview of the three Dow Jones Industrial Average companies that are reporting their…

Jon C. Ogg | Jan 30, 2016 at 10:50 AM EST

5 Dow Stocks Getting Slammed in 2016 Have Not Even Reported Earnings Yet

Some of the Dow stocks that are down in 2016 haven't even reported earnings. This is the market bracing for…

Lee Jackson | Jan 29, 2016 at 9:05 AM EST

4 Out-Of-Favor Large-Cap Blue-Chip Dividend Stocks to Buy Now

Needless to say, the stock market can be a very cruel mistress. Companies can report great numbers, but if the…

Chris Lange | Jan 28, 2016 at 8:40 AM EST

Short Sellers Become More Selective on Major Pharma

The January 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Trey Thoelcke | Jan 28, 2016 at 6:15 AM EST

The 6 Most Shorted NYSE Stocks: Short Sellers Pile on Alcoa, Freeport-McMoRan

Perhaps not surprisingly, in early January, short interest was on the rise for most of the top six most heavily…

1 … 51 52 53 54 55 … 98

Pfizer : PFE

All Pfizer Articles

6 Biotech and Pharma Stocks Analysts Want You to Buy Now

Short Sellers Increase Bets in Major Pharma

The 6 Most Shorted NYSE Stocks: Short Sellers Pile on Alcoa, Freeport-McMoRan Again

Why Merrill Lynch Sees Big Upside in Pfizer (and Even More With Allergan)

Top Analyst Upgrades and Downgrades: Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce, Tesla, Yelp and More

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

How Analysts View Pfizer and Merck After Earnings

Merrill Lynch Has 4 Very Oversold Blue Chip Dividend Stocks to Buy Now

Investors OK With Pfizer Earnings, Not OK With Guidance

What to Expect From Pfizer Earnings

Top 3 Dow Earnings for the Coming Week

5 Dow Stocks Getting Slammed in 2016 Have Not Even Reported Earnings Yet

4 Out-Of-Favor Large-Cap Blue-Chip Dividend Stocks to Buy Now

Short Sellers Become More Selective on Major Pharma

The 6 Most Shorted NYSE Stocks: Short Sellers Pile on Alcoa, Freeport-McMoRan

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Brinker CEO Kevin Hochman: “We Are Firing on All Cylinders” After 20 Straight Quarters of Growth

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Pfizer : PFE

All Pfizer Articles

6 Biotech and Pharma Stocks Analysts Want You to Buy Now

Short Sellers Increase Bets in Major Pharma

The 6 Most Shorted NYSE Stocks: Short Sellers Pile on Alcoa, Freeport-McMoRan Again

Why Merrill Lynch Sees Big Upside in Pfizer (and Even More With Allergan)

Top Analyst Upgrades and Downgrades: Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce, Tesla, Yelp and More

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

How Analysts View Pfizer and Merck After Earnings

Merrill Lynch Has 4 Very Oversold Blue Chip Dividend Stocks to Buy Now

Investors OK With Pfizer Earnings, Not OK With Guidance

What to Expect From Pfizer Earnings

Top 3 Dow Earnings for the Coming Week

5 Dow Stocks Getting Slammed in 2016 Have Not Even Reported Earnings Yet

4 Out-Of-Favor Large-Cap Blue-Chip Dividend Stocks to Buy Now

Short Sellers Become More Selective on Major Pharma

The 6 Most Shorted NYSE Stocks: Short Sellers Pile on Alcoa, Freeport-McMoRan

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Brinker CEO Kevin Hochman: “We Are Firing on All Cylinders” After 20 Straight Quarters of Growth

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up